Attached files
| file | filename |
|---|---|
| 8-K - 8-K - LUMOS PHARMA, INC. | nlnk-20150106x8k.htm |
| EX-10.2 - EXHIBIT - 2015 - LUMOS PHARMA, INC. | nlnk-20150106x8kxex102.htm |
Exhibit 10.1
2014 Bonus Awards | ||||||||
Name and Title | Bonus Target* | Goal Percentage Achieved | Bonus Target Achieved* | 2014 Salary | Total Cash Bonus Awarded | |||
Charles J. Link, Jr., M.D. | 60 | % | 150 | % | 90 | % | $573,200 | $515,880 |
Chairman of the Board and Chief | ||||||||
Executive and Scientific Officer | ||||||||
Nicholas N. Vahanian, M.D. | 50 | % | 150 | % | 75 | % | $453,600 | $340,200 |
President and Chief Medical Officer | ||||||||
Gordon H. Link, Jr. | 35 | % | 75 | % | 26.25 | % | $295,200 | $77,490 |
Chief Financial Officer (1) | ||||||||
W. Jay Ramsey, M.D., Ph.D. | 35 | % | 150 | % | 52.5 | % | $312,200 | $163,905 |
Clinical and Regulatory Affairs Officer | ||||||||
Brian Wiley | 30 | % | 150 | % | 45 | % | $262,500 | $118,125 |
Vice President of Business Development | ||||||||
* Bonus Targets listed as percentage of 2014 Base Salary | ||||||||
(1) Mr. Gordon Link's employment was terminated on September 30, 2014. His separation agreement provided that he would be paid a prorated bonus equal to 75% of his target bonus for the year. | ||||||||